Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ZBIOZenas BioPharma, Inc.

Nasdaq · CIK 0001953926
Filer category<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts224

Identity from submissions API

NameZenas BioPharma, Inc.
CIK0001953926
TickersZBIO
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone857-271-2954
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Zenas BioPharma (Cayman) Ltd (2022-11-15T05:00:00.000Z → 2022-11-15T05:00:00.000Z)
Business address
852 WINTER STREET, SUITE 250
WALTHAM
MA
02451
MA
Mailing address
852 WINTER STREET, SUITE 250
WALTHAM
MA
02451
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

196 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902219-26-000362 005-94625 261557833 34 17405
2026-11-06 8-K FORM 8-K 8.01,9.01 0001104659-26-123885 001-42270 261532145 34 211774 1 1
2026-11-06 424B5 424B5 0001104659-26-123876 333-290777 261532109 33 680292 1 1
2026-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001326732-26-000066 005-94625 261528706 34 7307
2026-11-05 10-Q 10-Q 0001104659-26-123040 001-42270 261524777 34 9102588 1 1
2026-11-05 8-K FORM 8-K 2.02,9.01 0001104659-26-123035 001-42270 261524736 34 282634 1 1
2026-10-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003867 005-94625 261491708 34 10984
2026-10-13 8-K FORM 8-K 7.01,9.01 0001104659-26-115151 001-42270 261454254 34 253446 1 1
2026-09-11 S-3ASR S-3ASR 0001104659-26-107108 333-298895 261374980 33 395918 1 1
2026-09-11 S-8 FORM S-8 0001104659-26-107105 333-298894 261374961 33 191321 1 1
2026-09-08 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000902219-26-000315 005-94625 261363399 34 17283
2026-09-08 3 xslF345X06/ownership.xml 0001213900-26-097827 3969
2026-09-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-097825 005-94625 261363319 34 11832
2026-09-02 4 OWNERSHIP DOCUMENT 0001104659-26-104728 5669
2026-09-02 3 OWNERSHIP DOCUMENT 0001104659-26-104726 11086
2026-08-19 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001953107-26-000015 005-94625 261296786 34 9414
2026-08-19 144 xsl144X01/primary_doc.xml 0001968582-26-000858 001-42270 261295367 33 4904
2026-08-17 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001072613-26-000694 005-94625 261288058 34 153178
2026-08-13 10-Q 10-Q 0001104659-26-095448 001-42270 261270016 34 8549351 1 1
2026-08-13 8-K FORM 8-K 2.02,5.02,9.01 0001104659-26-095437 001-42270 261269988 34 313017 1 1
2026-06-17 4 4 0001193125-26-274473 5443
2026-06-17 4 OWNERSHIP DOCUMENT 0001104659-26-075257 5636
2026-06-17 4 OWNERSHIP DOCUMENT 0001104659-26-075256 5830
2026-06-17 4 OWNERSHIP DOCUMENT 0001104659-26-075255 5673
2026-06-17 4 OWNERSHIP DOCUMENT 0001104659-26-075254 5861
2026-06-17 4 OWNERSHIP DOCUMENT 0001104659-26-075253 5735
2026-06-17 4 OWNERSHIP DOCUMENT 0001104659-26-075252 6038
2026-06-17 4 OWNERSHIP DOCUMENT 0001104659-26-075251 5699
2026-06-17 4 OWNERSHIP DOCUMENT 0001104659-26-075250 7653
2026-06-17 4 OWNERSHIP DOCUMENT 0001104659-26-075249 7669
2026-05-18 4 OWNERSHIP DOCUMENT 0001104659-26-063362 7718
2026-05-13 10-Q 10-Q 0001104659-26-059735 001-42270 26970821 34 9095390 1 1
2026-05-13 8-K FORM 8-K 2.02,5.02,5.07,9.01 0001104659-26-059700 001-42270 26970789 34 288256 1 1
2026-05-05 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-055643 005-94625 26943370 34 33591
2026-04-29 4 OWNERSHIP DOCUMENT 0001104659-26-051889 9834
2026-04-02 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-039279 005-94625 26835720 34 12682
2026-04-02 4 OWNERSHIP DOCUMENT 0001104659-26-039240 6072
2026-04-01 4 OWNERSHIP DOCUMENT 0001104659-26-038546 10825
2026-03-31 4 OWNERSHIP DOCUMENT 0001104659-26-038031 9835
2026-03-31 4 OWNERSHIP DOCUMENT 0001104659-26-037865 6397
2026-03-31 8-K FORM 8-K 1.01,2.03,8.01,9.01 0001104659-26-037821 001-42270 26822662 34 2199443 1 1
2026-03-30 424B5 424B5 0001104659-26-036536 333-290777 26810355 33 1521907 1 1
2026-03-30 424B5 424B5 0001104659-26-036534 333-290777 26810351 33 902722 1 1
2026-03-27 FWP FWP 0001104659-26-035494 333-290777 26800746 34 30420
2026-03-27 FWP FWP 0001104659-26-035475 333-290777 26800710 34 107065
2026-03-26 424B5 424B5 0001104659-26-035241 333-290777 26798736 33 1328916
2026-03-26 424B5 424B5 0001104659-26-035237 333-290777 26798683 33 754409
2026-03-26 FWP FWP 0001104659-26-035203 333-290777 26798317 34 29941
2026-03-16 DEFA14A DEFA14A 0001104659-26-028064 001-42270 26754590 34 338896
2026-03-16 ARS ARS 0001104659-26-028063 001-42270 26754589 34 4055214
2026-03-16 DEF 14A DEF 14A 0001104659-26-028062 001-42270 26754586 34 2018634 1 1
2026-03-16 S-8 FORM S-8 0001104659-26-027991 333-294311 26754485 33 192018 1 1
2026-03-16 10-K 10-K 0001104659-26-027964 001-42270 26754459 34 15330780 1 1
2026-03-16 8-K FORM 8-K 2.02,9.01 0001104659-26-027961 001-42270 26754450 34 293655 1 1
2026-02-13 4 OWNERSHIP DOCUMENT 0001104659-26-015387 6030
2026-02-13 4 OWNERSHIP DOCUMENT 0001104659-26-015342 10148
2026-02-13 8-K FORM 8-K 5.02,9.01 0001104659-26-015314 001-42270 26634203 34 240149 1 1
2026-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000571 005-94625 26602118 34 11614
2026-02-03 4 OWNERSHIP DOCUMENT 0001104659-26-009756 7571
2026-01-28 424B7 424B7 0001104659-26-007414 333-290999 26572629 33 24506
2026-01-14 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-26-003758 005-94625 26533620 34 35930
2026-01-09 4 OWNERSHIP DOCUMENT 0001104659-26-002589 11497
2026-01-05 8-K FORM 8-K 2.02,7.01,8.01,9.01 0001104659-26-000402 001-42270 26503887 34 268764 1 1
2025-12-19 S-8 FORM S-8 0001104659-25-123261 333-292309 251588391 33 238753 1 1
2025-12-15 8-K FORM 8-K 5.02,9.01 0001104659-25-121182 001-42270 251572020 34 661953 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001388325-25-000027 005-94625 251488694 34 7591
2025-11-12 10-Q 10-Q 0001104659-25-109753 001-42270 251468803 34 9147747 1 1
2025-11-12 8-K FORM 8-K 2.02,9.01 0001104659-25-109737 001-42270 251468759 34 277491 1 1
2025-10-27 8-K FORM 8-K 7.01,8.01,9.01 0001104659-25-102317 001-42270 251417455 34 253480 1 1
2025-10-21 S-3ASR S-3ASR 0001104659-25-101271 333-290999 251407641 33 532497 1 1
2025-10-15 3 xslF345X02/ownership.xml 0001213900-25-098960 3832
2025-10-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-098959 005-94625 251393342 34 17668
2025-10-14 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001953107-25-000010 005-94625 251392768 34 11447
2025-10-14 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-239173 005-94625 251392760 34 323232
2025-10-14 4 4 0001193125-25-239158 7041
2025-10-14 4 4 0001193125-25-239153 10769
2025-10-14 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-238370 005-94625 251390080 34 26856
2025-10-14 4 4 0001193125-25-238326 8690
2025-10-09 4 OWNERSHIP DOCUMENT 0001104659-25-098413 7529
2025-10-09 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-098408 005-94625 251385847 34 29366
2025-10-09 4 OWNERSHIP DOCUMENT 0001104659-25-098362 10479
2025-10-09 4 xslF345X05/ownership.xml 0000919574-25-006031 8445
2025-10-08 S-3ASR S-3ASR 0001104659-25-097950 333-290777 251382679 33 1519389 1 1
2025-10-08 8-K FORM 8-K 1.01,2.02,3.02,7.01,8.01,9.01 0001104659-25-097663 001-42270 251381171 34 16304096 1 1
2025-09-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002257 005-94625 251299156 34 11614
2025-09-02 8-K FORM 8-K 1.01,2.01,2.03,7.01,9.01 0001104659-25-085982 001-42270 251282935 34 241135 1 1
2025-08-12 S-8 FORM S-8 0001104659-25-076498 333-289510 251204111 33 258695 1 1
2025-08-12 10-Q 10-Q 0001558370-25-011147 001-42270 251204019 34 7963455 1 1
2025-08-12 8-K FORM 8-K 2.02,9.01 0001104659-25-076464 001-42270 251204006 34 250329 1 1
2025-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002136 005-94625 251188510 34 11228
2025-06-12 4 4 0000950170-25-085531 5253
2025-06-12 4 OWNERSHIP DOCUMENT 0001104659-25-058943 5716
2025-06-12 4 OWNERSHIP DOCUMENT 0001104659-25-058940 5648
2025-06-12 4 OWNERSHIP DOCUMENT 0001104659-25-058935 5900
2025-06-12 4 OWNERSHIP DOCUMENT 0001104659-25-058933 5598
2025-06-12 4 OWNERSHIP DOCUMENT 0001104659-25-058930 5701
2025-06-12 4 OWNERSHIP DOCUMENT 0001104659-25-058927 11629
2025-06-12 4 OWNERSHIP DOCUMENT 0001104659-25-058924 5562
2025-06-12 4 OWNERSHIP DOCUMENT 0001104659-25-058922 5536
2025-06-12 4 OWNERSHIP DOCUMENT 0001104659-25-058918 5499
2025-06-12 4 OWNERSHIP DOCUMENT 0001104659-25-058914 5691
2025-06-12 8-K FORM 8-K 5.02,5.07 0001104659-25-058892 001-42270 251042900 34 198365 1 1
2025-06-06 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-057322 005-94625 251030745 34 26328
2025-06-04 8-K FORM 8-K 7.01,9.01 0001104659-25-056215 001-42270 251021866 34 6273165 1 1
2025-05-15 10-Q 10-Q 0001558370-25-007803 001-42270 25948700 34 7118558 1 1
2025-05-15 8-K FORM 8-K 2.02,9.01 0001104659-25-048948 001-42270 25948677 34 282263 1 1
2025-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-001413 005-94625 25933088 34 11601
2025-04-28 4/A OWNERSHIP DOCUMENT 0001104659-25-039771 5685
2025-04-28 ARS ARS 0001104659-25-039770 001-42270 25875923 34 2915484
2025-04-28 DEFA14A DEFA14A 0001104659-25-039768 001-42270 25875919 34 339266
2025-04-28 DEF 14A DEF 14A 0001104659-25-039765 001-42270 25875912 34 2042208 1 1
2025-04-17 4 OWNERSHIP DOCUMENT 0001104659-25-035996 5725
2025-04-01 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-048850 005-94625 25801809 34 7280
2025-03-21 3 OWNERSHIP DOCUMENT 0001104659-25-026630 11601
2025-03-11 S-8 FORM S-8 0001104659-25-022386 333-285694 25725802 33 74544
2025-03-11 10-K 10-K 0001558370-25-002631 001-42270 25725757 34 12970717 1 1
2025-02-19 4 OWNERSHIP DOCUMENT 0001104659-25-015145 6370
2025-02-11 4 OWNERSHIP DOCUMENT 0001104659-25-011505 5173
2025-02-05 8-K FORM 8-K 2.02,9.01 0001104659-25-009368 001-42270 25590887 34 267673 1 1
2024-12-18 4 OWNERSHIP DOCUMENT 0001104659-24-129778 5724
2024-12-18 4 OWNERSHIP DOCUMENT 0001104659-24-129776 5615
2024-12-04 4 OWNERSHIP DOCUMENT 0001104659-24-125677 8334
2024-12-02 8-K FORM 8-K 7.01,9.01 0001104659-24-124616 001-42270 241519538 34 36312233 1 1
2024-11-20 4 OWNERSHIP DOCUMENT 0001104659-24-121081 8332
2024-11-12 SC 13G filing.txt 0000315066-24-002940 005-94625 241445055 34 8089
2024-11-12 10-Q 10-Q 0001558370-24-015162 001-42270 241443356 34 10933741 1 1
2024-11-12 8-K FORM 8-K 2.02,9.01 0001104659-24-116346 001-42270 241443259 34 273133 1 1
2024-10-21 SC 13G SC 13G 0001326732-24-000055 005-94625 241383696 34 47053
2024-09-25 SC 13G NEA 18 VENTURE GROWTH EQUITY, L.P. -- ZENAS BIOPHARMA, INC. 13G 0001072613-24-000733 005-94625 241325689 34 411160
2024-09-23 SC 13D SC 13D 0001193125-24-223899 005-94625 241317366 34 290077
2024-09-23 SC 13D SC 13D 0001193125-24-223879 005-94625 241317329 34 134813
2024-09-23 SC 13D SC 13D 0001104659-24-102046 005-94625 241316431 34 71735
2024-09-20 4 OWNERSHIP DOCUMENT 0001104659-24-101773 12745
2024-09-18 4 OWNERSHIP DOCUMENT 0001104659-24-101030 15663
2024-09-18 4 xslF345X05/form4-09182024_040906.xml 0001415889-24-023609 13733
2024-09-17 4/A OWNERSHIP DOCUMENT 0001104659-24-100766 31831
2024-09-17 4/A OWNERSHIP DOCUMENT 0001104659-24-100765 22976
2024-09-17 4 xslF345X05/ownership.xml 0000919574-24-005530 5511
2024-09-16 4 OWNERSHIP DOCUMENT 0001104659-24-100339 5550
2024-09-16 4 OWNERSHIP DOCUMENT 0001104659-24-100338 5551
2024-09-16 4 OWNERSHIP DOCUMENT 0001104659-24-100337 5518
2024-09-16 4 OWNERSHIP DOCUMENT 0001104659-24-100335 5612
2024-09-16 4 OWNERSHIP DOCUMENT 0001104659-24-100333 21328
2024-09-16 4 OWNERSHIP DOCUMENT 0001104659-24-100332 5969
2024-09-16 4 4 0000950170-24-106979 17827
2024-09-16 4 OWNERSHIP DOCUMENT 0001104659-24-100330 31158
2024-09-16 4 OWNERSHIP DOCUMENT 0001104659-24-100328 5620
2024-09-16 4 4 0000950170-24-106978 22987
2024-09-16 4 OWNERSHIP DOCUMENT 0001104659-24-100327 5715
2024-09-16 4 OWNERSHIP DOCUMENT 0001104659-24-100326 5729
2024-09-16 4 OWNERSHIP DOCUMENT 0001104659-24-100325 22402
2024-09-16 S-8 FORM S-8 0001104659-24-100244 333-282151 241301604 33 287678
2024-09-16 8-K FORM 8-K 5.03,9.01 0001104659-24-100177 001-42270 241301048 34 363383 1 1
2024-09-13 424B4 424B4 0001104659-24-099805 333-281713 241298039 33 4934923
2024-09-12 SEC STAFF LETTER filename1.pdf 9999999997-24-003875 64340
2024-09-12 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-09-12 16:00:00 9999999995-24-002815 333-281713 241296370 33 1802
2024-09-12 3 OWNERSHIP DOCUMENT 0001104659-24-099459 7655
2024-09-12 3 OWNERSHIP DOCUMENT 0001104659-24-099458 11070
2024-09-12 3 OWNERSHIP DOCUMENT 0001104659-24-099456 15134
2024-09-12 3 OWNERSHIP DOCUMENT 0001104659-24-099455 11127
2024-09-12 3 OWNERSHIP DOCUMENT 0001104659-24-099454 16601
2024-09-12 3 OWNERSHIP DOCUMENT 0001104659-24-099453 15825
2024-09-12 3 3 0000950170-24-106176 19160
2024-09-12 3 3 0000950170-24-106174 143033
2024-09-12 3 xslF345X02/form3-09132024_010951.xml 0001415889-24-023342 8520
2024-09-12 3 OWNERSHIP DOCUMENT 0001104659-24-099451 11084
2024-09-12 3 OWNERSHIP DOCUMENT 0001104659-24-099450 12329
2024-09-12 3 OWNERSHIP DOCUMENT 0001104659-24-099449 11209
2024-09-12 3 OWNERSHIP DOCUMENT 0001104659-24-099448 16557
2024-09-12 3 OWNERSHIP DOCUMENT 0001104659-24-099447 14141
2024-09-12 3 OWNERSHIP DOCUMENT 0001104659-24-099446 20337
2024-09-12 S-1MEF S-1MEF 0001104659-24-099444 333-282082 241296284 33 64287
2024-09-12 CERT 8A_Cert_ZBIO.pdf 0001354457-24-000675 001-42270 241294373 34 762516
2024-09-10 8-A12B 8-A12B 0001104659-24-098571 001-42270 241289980 34 16721
2024-09-10 CORRESP filename1.htm 0001104659-24-098570 10533
2024-09-10 CORRESP filename1.htm 0001104659-24-098569 9965
2024-09-06 S-1/A S-1/A 0001104659-24-097538 333-281713 241282886 33 7878356
2024-08-27 CORRESP filename1.htm 0001104659-24-093440 82904
2024-08-22 S-1 S-1 0001104659-24-091950 333-281713 241231584 33 7133109
2024-07-25 DRSLTR filename1.htm 0001104659-24-082708 34661
2024-07-24 UPLOAD filename1.pdf 0000000000-24-008374 377-07069 42756
2024-07-16 DRSLTR filename1.htm 0001104659-24-080237 37235
2024-07-05 UPLOAD filename1.pdf 0000000000-24-007645 377-07069 42702
2024-06-26 DRSLTR filename1.htm 0001104659-24-075222 30510
2024-06-26 DRS/A filename1.htm 0001104659-24-075220 377-07069 241074535 33 4954755
2024-06-18 UPLOAD filename1.pdf 0000000000-24-006977 377-07069 43514
2024-06-14 DRSLTR filename1.htm 0001104659-24-071622 26822
2024-06-14 DRS/A filename1.htm 0001104659-24-071620 377-07069 241043886 33 4934297
2024-05-28 UPLOAD filename1.pdf 0000000000-24-006102 377-07069 45344
2024-05-16 DRS/A filename1.htm 0001104659-24-062092 377-07069 24952931 33 4949462
2024-05-15 DRSLTR filename1.htm 0001104659-24-062094 97091
2024-05-14 D xslFormDX01/primary_doc.xml 06b 0001953926-24-000001 021-513274 24945155 33 15440
2024-02-21 SEC STAFF LETTER filename1.pdf 9999999997-24-000404 65425
2024-02-21 UPLOAD filename1.pdf 0000000000-24-001972 377-07069 62130
2024-01-25 DRS filename1.htm 0001104659-24-006759 377-07069 24563312 33 6694703
2022-11-15 D xslFormDX01/primary_doc.xml 06b 0001953926-22-000001 021-464885 221391600 33 12810

Latest XBRL company facts

One latest value per concept from companyfacts (224 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 67.82M 2026-10-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
dei EntityPublicFloat Entity Public Float USD 259.30M 2025-06-30 2025 FY 10-K 2026-03-16 0001104659-26-027964
ffd NetFeeAmt NetFeeAmt USD 10,934.79 2026-11-05 424B5 2026-11-06 0001104659-26-123876
ffd NrrtvMaxAggtOfferingPric NrrtvMaxAggtOfferingPric USD 200.00M 2026-11-05 424B5 2026-11-06 0001104659-26-123876
ffd TtlFeeAmt TtlFeeAmt USD 17,400 2026-11-05 424B5 2026-11-06 0001104659-26-123876
ffd TtlOfferingAmt TtlOfferingAmt USD 200.00M 2026-11-05 424B5 2026-11-06 0001104659-26-123876
ffd TtlOffsetAmt TtlOffsetAmt USD 6,465.21 2026-11-05 424B5 2026-11-06 0001104659-26-123876
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-11-05 424B5 2026-11-06 0001104659-26-123876
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 7.06M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 49,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 53.74M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1.53M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.26M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.28B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 17.28M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 35.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD -2.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 8.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap Assets Assets USD 675.22M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap AssetsCurrent Assets, Current USD 603.45M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 1.10M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 470.40M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 469.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 177.78M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 647.10M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 177.78M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 67.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 4.50M 2024-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015162
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 29.66M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 175.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 67.80M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 67.80M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap CommonStockValue Common Stock, Value, Issued USD 7,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -302.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 10.10M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 449.61M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 20.30M 2023-12-31 2024 FY 10-K 2025-03-11 0001558370-25-002631
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 123,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD -79,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD -79,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap DebtRelatedCommitmentFeesAndDebtIssuanceCosts Debt Related Commitment Fees and Debt Issuance Costs USD 3.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest USD 0 2024-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015162
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2024-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015162
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterest DebtSecuritiesAvailableForSaleExcludingAccruedInterest USD 0 2024-06-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015162
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 0 2024-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015162
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 227,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 2.03M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 204.93M 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 30.64M 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 1.06M 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 65.45M 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 211.20M 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 43.70M 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration USD 47.80M 2024-12-31 2024 FY 10-K 2025-03-11 0001558370-25-002631
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 210.40M 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 817,000 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 25.74M 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 10.02M 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 3.07M 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 203.87M 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 1.06M 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 100,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap Depreciation Depreciation USD 14,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0001558370-25-002631
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -4.91 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -4.91 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.239 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 2.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure -0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap EffectiveIncomeTaxRateReconciliationDispositionOfAssets Effective Income Tax Rate Reconciliation, Disposition of Asset, Percent pure -0.003 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.002 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.029 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 108,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 12.57M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015162
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015162
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD 846,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0001558370-25-002631
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances USD 20.00M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-11 0001558370-25-002631
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements USD 21.15M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0001558370-25-002631
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 20.30M 2023-12-31 2024 FY 10-K 2025-03-11 0001558370-25-002631
us-gaap ForeignCurrencyTransactionGainLossAfterTax ForeignCurrencyTransactionGainLossAfterTax USD 300,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -107,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 60.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -388.51M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -301.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 10.69M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 15,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 163,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 90.24M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -79.34M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -41,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -108,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 10.79M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -53,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 1.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -813,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD 530,000 2024-01-01 2024-06-30 2025 Q2 10-Q 2025-08-12 0001558370-25-011147
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 5.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap InterestExpenseDebt Interest Expense, Debt USD 4.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 7.33M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap InterestPayableCurrent Interest Payable, Current USD 2.89M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 15.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 1.39M 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.16M 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 229,000 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 239,000 2025-09-30 2025 Q3 10-Q 2025-11-12 0001104659-25-109753
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 66,000 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap Liabilities Liabilities USD 462.91M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 675.22M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap LiabilitiesCurrent Liabilities, Current USD 64.04M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 398.87M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 78.64M 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap LongTermInvestments Long-term Investments USD 61.77M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 223.24M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 532.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -275.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -190.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -301.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -104.38M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015162
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -104.38M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015162
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -12.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap NotesAssumed1 Notes Assumed USD 21.15M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap OperatingExpenses Operating Expenses USD 299.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -288.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 600,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015162
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 1.33M 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.22M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 318,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 1.59M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.083 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 2.03M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap OtherAssetsMiscellaneousNoncurrent Other Assets, Miscellaneous, Noncurrent USD 218,000 2025-12-31 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 8.39M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD 89,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -1.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -48,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic Participating Securities, Distributed and Undistributed Earnings (Loss), Basic USD 28.12M 2023-07-01 2023-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015162
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 1.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap PaymentsOfDividendsPreferredStockAndPreferenceStock Payments of Ordinary Dividends, Preferred Stock and Preference Stock USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0001558370-25-002631
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 548,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 30.00M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001104659-26-095448
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 545.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap PreferredStockConvertibleConversionRatio PreferredStockConvertibleConversionRatio pure 1 2024-12-31 2024 FY 10-K 2025-03-11 0001558370-25-002631
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 25.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 18.14M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 8.17M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 223.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 234.39M 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-12 0001104659-25-109753
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 75.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 178.38M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap ProceedsFromIssuanceOfSecuredDebt Proceeds from Issuance of Secured Debt USD 73.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 328.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 9.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 1.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 19,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationFairValueAcquired Research and Development Asset Acquired Other than Through Business Combination, Fair Value Acquired USD 57.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 181.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 90,000 2024-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 86,000 2023-12-31 2024 FY 10-K 2025-03-11 0001558370-25-002631
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.07B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 11.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap Revenues Revenues USD 11.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 1.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap SecuredLongTermDebt Secured Long-term Debt, Noncurrent USD 76.12M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 35.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 511,100 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-12 0001558370-25-011147
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 11.94 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-12 0001558370-25-011147
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 1.35M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 11.94 2025-06-30 2025 Q2 10-Q 2025-08-12 0001558370-25-011147
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-12 0001558370-25-011147
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 70.46M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 4.84M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 12.41 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 12.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 721,713 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 14.73 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 2.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 144.55M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 11.67M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 14.78 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 144.55M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 11.67M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 14.78 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 8.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 12.74 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 19.97 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 17 2024-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015162
us-gaap ShortTermInvestments Short-term Investments USD 407.53M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 212.31M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 15.22M 2024-09-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015162
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 712,572 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 449.61M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 597,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 234.39M 2024-07-01 2024-09-30 2025 Q3 10-Q 2025-11-12 0001104659-25-109753
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 7.90M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 250.09M 2023-12-31 2024 FY 10-K 2025-03-11 0001558370-25-002631
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 250.97M 2023-12-31 2024 FY 10-K 2025-03-11 0001558370-25-002631
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 100.62M 2023-12-31 2024 FY 10-K 2025-03-11 0001558370-25-002631
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 100.62M 2023-12-31 2024 FY 10-K 2025-03-11 0001558370-25-002631
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 100.62M 2023-12-31 2024 FY 10-K 2025-03-11 0001558370-25-002631
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 113.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap VariableLeaseCost Variable Lease, Cost USD 300,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-16 0001104659-26-027964
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 360,473 2023-07-01 2023-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015162
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 61.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 61.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123040

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →